HMOX1 and nasopharyngeal carcinoma: We thus anticipated that, for those NPC patients resistant to radiotherapy, combined treatment by radiotherapy and HO inhibitors, such as PEG-ZnPP, may exhibit superior therapeutic effect, which needs further investigation.